Nefazodone-induced liver failure - A case report;Akutes leberversagen unter nefazodon-therapie? Ein fallbericht

Nervenarzt

Volumn 73, Issue 7, 2002, Pages 686-689

  Ehrentraut, S ^a   Rothenhausler H B ^a   Gerbes, A L ^a   Rau, H G ^a   Thiel, M ^a   Schirren, C A ^a   Kapfhammer, H P ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Acute liver failure; Consulting psychiatry; Liver transplantation; Nefazodone

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; DIHYDROERGOTAMINE MESILATE; DOXEPIN; LIVER ENZYME; MOCLOBEMIDE; MORADORM; NEFAZODONE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; TRIAZOLAM;

ADULT; ARTICLE; CASE REPORT; DEPRESSION; DISEASE COURSE; DRUG FATALITY; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; HUMAN; LIVER FAILURE; LIVER FUNCTION TEST; LIVER TOXICITY; LIVER TRANSPLANTATION; MALE; RECURRENT DISEASE;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; FATAL OUTCOME; HEPATITIS, TOXIC; HUMANS; LIVER FAILURE, ACUTE; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RECURRENCE; TRIAZOLES;

EID: 0036946898     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-002-1350-z     Document Type: Article

References (27)

1. Aranda-Michel J, Koehler A, Bejarano PA et al. (1999) Nefazodone-induced liver failure: report of three cases. Ann Intern Med 130:285-288
2. Arzneitmittelkommission der deutschen Ärzteschaft (2001) Hepatotoxizität des neueren Antidepressivums Nefazodon. Dtsch Ärztebl 98:60
3. Barbhaiya R, Shukla UA, Natarajan CS, Behr DA, Greene DS, Sainati SM (1995) Single- and multiple-dose pharmakokinetics of nefazodone in patients with hepatic cirrhosis. Clin Pharmacol Ther 58:390-398
4. Barbhaiya RH, Shukla UA, Chaikin P, Greene DS, Marathe PH (1996) Nefazodone pharmacokinetics: assessment of nonlinearity, intra-subject variability and time to attain steady-state plasma concentrations after dose escalation and de-escalation. Eur J Clin Pharmacol 50:101-107
5. Beck PL, Bridges RJ, Demetrick DJ, Kelly JK, Lee SS (1993) Chronic active hepatitis associated with trazodone therapy. Ann Intern Med 118:791-792
6. Berkelhammer C, Kher N, Berry C, Largosa A (1995) Nortriptyline-induced fulminant hepatic failure. J Clin Gastroenterol 20:54-56
7. Cai Q, Benson MA, Talbot TJ, Devadas G, Swanson HJ, Olson JL, Kirchner JP (1999) Acute hepatitis due to fluoxetine therapy. Mayo Clin Proc 74:692-694
8. Chu AG, Gunsolly BL, Summers RW, Alexander B, McChesney C, Tanna VL (1983) Trazodone and liver toxicity. Ann Intern Med 99:128-129
9. Davis M (1991) Hepatotoxity of antidepressants. Int Clin Psychopharmacol 6:97-103
10. De Man RA (1997) Severe hepatitis attribued to paroxetine. Ned Tijdschr Geneeskd 141:540-542
11. Eloubeidi MA, Gaede JT, Swaim MW (2000) Reversible nefazodone-induced liver failure. Dig Dis Sci 45:1036-1038
12. Gomez-Gil E, Salmeron JM, Mas A (1996) Phenelzine-induced fulminant hepatic failure. Ann Int Med 124:692-693
13. Helmchen C, Boerner RJ, Meyendorf R, Hegerl U (1996) Reversible hepatotoxity of paroxetine in a patient with major depression. Pharmacopsychiatry 29:223-226
14. Horsmans Y, De Clercq M,Sempoux C (1999) Venlafaxine-associated hepatitis. Ann Intern Med 130:944
15. Hull M, Jones R, Bendall M (1994) Fatal hepatic necrosis associated with trazodone and neuroleptic drugs. BMJ 309:378
16. Ilan Y, Samuel D, Reynes M, Tur-Kaspa R (1996) Hepatic failure associated with imipramine therapy. Pharmacopsychiatry 29:79-80
17. Kapfhammer HP (1999) Depressiv-ängstliche Störungen bei somatischen Erkrankungen. In: Möller HJ, Laux G, Kapfhammer HP (Hrsg) Psychiatrie und Psychotherapie. Springer, Berlin Heidelberg New York, S 1488-1520
18. Lucena MI, Andrade RJ, Gomez-Outes A, Rubio M, Cabello MR (1999) Acute liver failure after treatment with nefazodone. Dig Dis Sci 44:2577-2579
19. Moltke LL, Greenblatt DJ, Granda BW, Grassi JM, Schmider J, Harmatz JS, Shader RI (1999) Nefazodone, meta-chlorophenylpiperazine, and their metabolites in vitro: cytochromes mediating transformation, and P450-3A4 inhibitory actions. Psychopharmacology 145:113-122
20. Odeh M, Misselevech I, Boss JH, Oliven A (2001) Severe hepatotoxicity with jaundice associated with paroxetine. Am J Gastroenterol 96:2494-2496
21. Pedersen AM, Enevoldsen HK (1996) Nortriptyline-induced hepatic failure. Ther Drug Monit 18:100-102
22. Schirren CA, Baretton G (2000) Nefazodone-induced acute liver failure (Letter). Am J Gastroenterol 95:1596-1597
23. Sheikh KH, Nies AS (1983) Trazodone and intrahepatic cholestasis. Ann Intern Med 99:572
24. Taylor DP, Carter RB, Eison AS, Mullins UL, Smith HL, Torrente JR, Wright RN, Yocca FD (1995) Pharmacology and neurochemistry of nefazodone,a novel antidepressant drug. J Clin Psychiatry 56:3-11
25. Van Battum PL, van de Vrie W, Metselaar HJ, Verstappen VM, Zondervan PE, de Man RA (2000) Acute liver failure ascribed to nefazodone: importance of postmarketing surveillance for recently introduced drugs. Ned Tijdschr Geneeskd 144:1964-1967
26. Weinstein RP, Gosselin JY (1988) Case report of hepatotoxicity associated with maprotiline. Can J Psychiatry 33:233-234
27. Zimmerman HJ (1999) Drug-induced liver disease. In: Schiff ER, Sorell MF, Maddrey WC (eds) Schiff's diseases of the liver. Lippincott-Raven Publ, Philadelphia, pp 973-1025